← Back to Search

Skin Biopsy for Gastrointestinal Motility Disorders

N/A
Waitlist Available
Led By Pankaj J Pasricha, MD
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up only one biopsy but analysis may take one year.
Awards & highlights

Study Summary

This trial is studying if skin biopsies can show signs of small fiber neuropathy in people with GI motility disorders that haven't gotten better with other treatments. This could help explain the cause of their condition.

Eligible Conditions
  • Gastrointestinal Dysmotility
  • Small Fiber Neuropathy

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~only one biopsy but analysis may take one year.
This trial's timeline: 3 weeks for screening, Varies for treatment, and only one biopsy but analysis may take one year. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Presence of small fiber neuropathy in skin biopsy samples

Trial Design

2Treatment groups
Experimental Treatment
Group I: Healthy participantsExperimental Treatment1 Intervention
Group II: Gastrointestinal dysmotility participantsExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Skin biopsy
2018
Completed Phase 4
~950

Find a Location

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor
2,256 Previous Clinical Trials
14,820,071 Total Patients Enrolled
1 Trials studying Gastrointestinal Dysmotility
5 Patients Enrolled for Gastrointestinal Dysmotility
Pankaj J Pasricha, MDPrincipal InvestigatorJohns Hopkins University
8 Previous Clinical Trials
1,409 Total Patients Enrolled
1 Trials studying Gastrointestinal Dysmotility
5 Patients Enrolled for Gastrointestinal Dysmotility

Media Library

Skin biopsy Clinical Trial Eligibility Overview. Trial Name: NCT04872452 — N/A
Gastrointestinal Dysmotility Research Study Groups: Healthy participants, Gastrointestinal dysmotility participants
Gastrointestinal Dysmotility Clinical Trial 2023: Skin biopsy Highlights & Side Effects. Trial Name: NCT04872452 — N/A
Skin biopsy 2023 Treatment Timeline for Medical Study. Trial Name: NCT04872452 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment for this trial still open?

"The clinical trial found on clinicaltrials.gov is no longer recruiting participants, as the last update was on August 25th 2022. Despite this, there are still 7 other medical studies actively enrolling people at present."

Answered by AI

Who else is applying?

What state do they live in?
Florida
Virginia
How old are they?
65+
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
What site did they apply to?
Johns Hopkins Bayview Medical Center
Recent research and studies
clinicaltrials.govStudy
Analysis of Cutaneous Nerve Biopsies in Gastrointestinal Motility Disorders
2023. "Analysis of Cutaneous Nerve Biopsies in Gastrointestinal Motility Disorders". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04872452.
~0 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top